Data from an epidemiological study are used to analyse the course of multiple sclerosis. It could be proved that the course of MS is not as haphazard as was often supposed. In general the course is described as being a chronic progressive one, in the majority of patients preceded by a relapsing-remitting period. In contrast to the relapsing-remitting phase the chronic progressive phase of the course does not show marks of being an autoimmune process. From recent data obtained by MRI and NMR spectroscopy it can be concluded that the chronic progression of handicaps in multiple sclerosis is related to neuronal and axonal damage. The relation between these different pathogenetic processes should be the aim of further research
Multiple sclerosis (MS) represents the most common acquired demyelinating disorder of the central ne...
Traditionally, multiple sclerosis has been categorised by distinct clinical descriptors—relapsing-re...
The pathogenesis of multiple sclerosis (MS) remains unknown. Although inflammation, demyelination an...
Data from an epidemiological study are used to analyse the course of multiple sclerosis. It could be...
Patients with a progressive form of multiple sclerosis have the worst prognosis. They can expect tha...
Major advancements have been achieved in our ability to diagnose multiple sclerosis (MS) and to comm...
Since the earliest clinical descriptions of multiple sclerosis (MS), it has been recognised that a m...
Multiple sclerosis (MS) is a common, complex neurological disease. The precise aetiology of MS is no...
Multiple sclerosis (MS) is a chronic, debilitating, autoimmune-mediated, inflammatory disease of the...
Multiple Sclerosis (MS) is an autoimmune disease driving inflammatory and degenerative processes tha...
In the majority of patients multiple sclerosis starts with a relapsing remitting course (RRMS), whic...
Multiple Sclerosis (MS) is characterized by attacks and remissions initially and in the majority of ...
THE mechanism of symptom production and remission in multiple sclerosis has interested neurologists ...
Multiple sclerosis (MS) is an inflammatory demyelinating disease affecting the central nervous syste...
Multiple sclerosis is primarily an infl ammatory disorder of the brain and spinal cord in which foca...
Multiple sclerosis (MS) represents the most common acquired demyelinating disorder of the central ne...
Traditionally, multiple sclerosis has been categorised by distinct clinical descriptors—relapsing-re...
The pathogenesis of multiple sclerosis (MS) remains unknown. Although inflammation, demyelination an...
Data from an epidemiological study are used to analyse the course of multiple sclerosis. It could be...
Patients with a progressive form of multiple sclerosis have the worst prognosis. They can expect tha...
Major advancements have been achieved in our ability to diagnose multiple sclerosis (MS) and to comm...
Since the earliest clinical descriptions of multiple sclerosis (MS), it has been recognised that a m...
Multiple sclerosis (MS) is a common, complex neurological disease. The precise aetiology of MS is no...
Multiple sclerosis (MS) is a chronic, debilitating, autoimmune-mediated, inflammatory disease of the...
Multiple Sclerosis (MS) is an autoimmune disease driving inflammatory and degenerative processes tha...
In the majority of patients multiple sclerosis starts with a relapsing remitting course (RRMS), whic...
Multiple Sclerosis (MS) is characterized by attacks and remissions initially and in the majority of ...
THE mechanism of symptom production and remission in multiple sclerosis has interested neurologists ...
Multiple sclerosis (MS) is an inflammatory demyelinating disease affecting the central nervous syste...
Multiple sclerosis is primarily an infl ammatory disorder of the brain and spinal cord in which foca...
Multiple sclerosis (MS) represents the most common acquired demyelinating disorder of the central ne...
Traditionally, multiple sclerosis has been categorised by distinct clinical descriptors—relapsing-re...
The pathogenesis of multiple sclerosis (MS) remains unknown. Although inflammation, demyelination an...